CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 394 enrolled
Drug / intervention
LY2189265 +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01468181
NCT01468181Phase 3Completed
CompareCT.gov

A 52-Week, Open-Label, Long-Term Safety Study of LY2189265 in Combination With Monotherapy of Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus

Eli Lilly and Company·interventional·Posted Nov 9, 2011·Updated Jan 29, 2015

In Brief

A Phase 3 clinical trial evaluating LY2189265, Sulfonylureas (SU), and 4 other interventions for Type 2 Diabetes Mellitus. Completed, enrolled 394 participants across 14 sites.

Detailed Summary

This was a 52-week, multicenter, non-randomized, open-label, Phase 3 long-term safety study in participants with type 2 diabetes mellitus who have inadequate glycemic control with monotherapy of oral antihyperglycemic medication (OAM).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesJapan
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 9, 2011
Enrollment StartNov 1, 2011
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.6 years ago

Interventions

LY2189265drug

Sulfonylureas (SU)drug

SU is a pre-study prescribed dose and is not being provided as part of the trial.

Biguanides (BG)drug

Biguanides is a pre-study prescribed dose and is not being provided as part of the trial.

alpha-glucosidase inhibitor (a-GI)drug

a-GI is a pre-study prescribed dose and is not being provided as part of the trial.

Thiazolidinedione (TZD)drug

TZD is a pre-study prescribed dose and is not being provided as part of the trial.

Glinidesdrug

Glinides is a pre-study prescribed dose and is not being provided as part of the trial.